Defective Hip Implant Side Effects Lawsuit News Update
Upcoming FDA Metal Hip Implant Meeting is Critical to Many of Those Suffering
- Ennis & Ennis News
06/27/2012 - With an FDA advisory panel meeting to discuss the safety and effectiveness of metal-on-metal hips June 27 and June 28, 2012, regulators are recommending frequent imaging and ion testing in the patients. The primary issues to be considered will be the role of imaging in patients who are symptomatic vs. those that are asymptomatic, as well as the determination of who should be tested for metal ion levels and the course of action taken by the physician based upon the test results.
This FDA meeting was prompted after metal hip implants were linked to almost 16,800 adverse events in the U.S. from 2000-2011, and upon review of registries, which reflected high rates of failure. The national registry in England and Wales revealed the revision surgery rate after five years for metal on metal implants was almost three times as high as other versions. Another registry by HealthEast Care System in Minnesota revealed the revisions rate was four times higher than metal and polyethelyne implants. The FDA Executive Summary Memorandum breaks down the results of six different registries, all of which are consistent with an increased failure rate in metal on metal hip implants.
While many physicians are no longer utilizing the metal-on-metal devices, thousands upon thousands of patients have already had these metal hip devices implanted. As a result, the FDA has already issued an order requiring manufacturers, such as Biomet, DePuy Orthopaedics, Encore Medical, Wright Medical, and Zimmer, to conduct post-market surveillance studies to collect more safety data on these devices, including data regarding metal ions in the bloodstream.
Ennis & Ennis, P.A continues to receive calls relating to the Johnson and Johnson’s DePuy and Pinnacle Hip Implants; Wright’s Conserve and Profemur Total Hip Systems; Biomet’s Active Articulation E1 Dual Mobility and M2a-Magnum Hip Systems; and Zimmer’s Durom Cup. “With the evidence of increased failure rate and metallosis associated with metal-on-metal hip implants, we advocate a recall on all of these devices,” commented Attorney Holly Ennis of Ennis & Ennis, P.A. “It is not necessary to keep them on the market because there are safer alternatives, such as the ceramic and polyethelyne devices, that do not carry the increased risk.”
Ennis & Ennis, P.A. recommends that anyone with a metal DePuy Hip Replacement or any other all-metal hip implant system, who is experiencing pain in the groin, hip or leg, swelling at or near the hip joint, or a limp/change in walking ability, first seek medical attention. Then file an adverse event report with the FDA at https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm Lastly, consult with an experienced attorney.
Ennis & Ennis, P.A. continues to offer free, nationwide, confidential consultations to anyone who has an all-metal hip replacement system by calling toll free 1-800-856-6405 or by going to www.ennislaw.com and completing an online case evaluation form.
Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. that concentrates its practice in mass torts and represents individuals against pharmaceutical companies and medical device makers.
Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $100 million in settlements for its clients.
If you or a loved one have been injured as a result of a defective metal on metal hip implant you may be entitled to compensation. Our experienced Hip Replacement Lawsuit Attorneys are here to answer any questions you may have about a hip replacement lawsuit or a possible hip replacement class action lawsuit. Fill out the free hip replacement lawsuit case evalution form on this page or contact our Hip Replacement Recall Lawsuit Lawyers directly by calling toll-free: 1.800.856.6405.